Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

Rifampin - Generic Drug Details

« Back to Dashboard

What are the generic sources for rifampin and what is the scope of freedom to operate?

is the generic ingredient in three branded drugs marketed by Emcure Pharms Ltd, Akorn, Sanofi Aventis Us, West-ward Pharms Int, Mylan Labs Ltd, Oxford Pharms, Lupin Pharms, Watson Pharms Teva, Hikma Pharms, Sandoz, Fresenius Kabi Usa, and Lannett, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Twenty-seven suppliers are listed for this compound.

Summary for Generic Name: rifampin

Drug Master File Entries: see list9
Suppliers / Packagers: see list27
Bulk Api Vendors: see list59
Clinical Trials: see list74
Patent Applications: see list8,381
Therapeutic Class:Antimycobacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:rifampin at DailyMed

Pharmacology for Ingredient: rifampin

Drug ClassRifamycin Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Pharms Teva
INJECTABLE;INJECTION206736-001Jan 19, 2016APRXNoNo► Subscribe► Subscribe
Sanofi Aventis Us
INJECTABLE;INJECTION050627-001May 25, 1989APRXYesYes► Subscribe► Subscribe
Hikma Pharms
INJECTABLE;INJECTION205039-001Mar 3, 2016APRXNoNo► Subscribe► Subscribe
INJECTABLE;INJECTION065502-001Sep 21, 2010APRXNoNo► Subscribe► Subscribe
CAPSULE;ORAL065390-002Mar 28, 2008ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus